Found 59 matching trials
Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes
PHASE1Our research is part of the global effort to develop a vaccine against HIV....
Location
Imperial College London
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
PHASE2This is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study. Cohort 1 w...
Location
University of Arizona
Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults
PHASE1DNA vaccines consist of small pieces of DNA also known as plasmids, and hav...
Location
Vince & Associates
Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers
PHASE1This is an open-label trial to evaluate the safety, tolerability and immuno...
Location
Central Kentucky Research Associates
Safety and Immunogenicity Study of GX-70 in TB Patient
PHASE1The purpose of this study is to determine the safety, tolerability, and imm...
Location
Multiple Locations
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
PHASE1Therapeutic HIV vaccines are designed to control HIV infection by boosting ...
Location
UCLA CARE Center CRS
IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer
PHASE2This phase II trial studies the effectiveness of ImmunoPulse IL-12® in trea...
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects
PHASE1This was an open-label study that evaluated the safety, tolerability, and i...
Location
Research and Education, Inc.
Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.
NAThis is a study to investigate the safety and efficacy of GX-188E administe...
Location
Seoul St. Mary's hospital
Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers
PHASE1This is an open label, phase 1 clinical trial of an intra-dermal booster do...
Location
Multiple Locations